근골격계 공동 연구 및 라이선싱 계약(2016-2025년)
Musculoskeletal Collaboration and Licensing Deals 2016-2025
상품코드 : 1708059
리서치사 : Current Partnering
발행일 : 2025년 04월
페이지 정보 : 영문 250+ Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,995 ₩ 5,733,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,995 ₩ 8,604,000
PDF (Multi User License - 2 to 5 Users) help
PDF 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,995 ₩ 11,474,000
PDF (Company Wide License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 바이오의약품 업계에 대해 조사분석했으며, 2016-2025년 근골격계 공동 연구·라이선싱 계약 476건에 관한 계약 조건 등의 상세 데이터를 제공하고 있습니다.

목차

개요

제1장 서론

제2장 근골격계 계약의 동향

제3장 근골격계 파트너 계약에 관한 재무적 계약 조건

제4장 주요 근골격계 계약과 교섭자

제5장 근골격계 계약 문서 디렉토리

제6장 근골격계 계약 : 치료 표적별

KSA
영문 목차

영문목차

Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the musculoskeletal deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of 476 musculoskeletal deals from 2016 to 2025.

The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of musculoskeletal dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in musculoskeletal dealmaking.

Chapter 3 covers the financial deal terms for deals signed in the musculoskeletal field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.

Chapter 4 provides a review of the top 25 most active biopharma companies in musculoskeletal dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive and detailed review of musculoskeletal deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of musculoskeletal deals listed by theraeutic target.

The report also includes numerous table and figures that illustrate the trends and activities in musculoskeletal deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Musculoskeletal Collaboration and Licensing Deals provides the reader with the following key benefits:

Report scope

Musculoskeletal Collaboration and Licensing Deals includes:

In Musculoskeletal Collaboration and Licensing Deals, the available deals are listed by:

Analyzing contract agreements allows due diligence of:

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in musculoskeletal dealmaking

Chapter 3 - Financial deal terms for musculoskeletal partnering

Chapter 4 - Leading musculoskeletal deals and dealmakers

Chapter 5 - Musculoskeletal contract document directory

Chapter 6 - Musculoskeletal dealmaking by therapeutic target

Table of figures

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기